scispace - formally typeset
Journal ArticleDOI

Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial.

Reads0
Chats0
TLDR
The efficacy of the macrolide agent azithromycin for treating shigellosis was evaluated and the oral form of the extended-spectrum cephalosporin cefixime, although active in vitro against multidrug-resistant Shigella strains, was ineffective in achieving clinical and bacteriologic cure.
Abstract
Background: Treatment of shigellosis is currently limited by the high prevalence of multidrug-resistant strains of Shigella. Objective: To determine the efficacy of azithromycin in the treatment of...

read more

Citations
More filters
Journal ArticleDOI

Acute Infectious Diarrhea

TL;DR: An otherwise healthy 23-year-old man presents after the acute onset of watery diarrhea that has persisted for two days, with associated nausea and cramping but no emesis and is febrile, with a temperature of 38.7°C (101°F).
Journal ArticleDOI

The macrolides: erythromycin, clarithromycin, and azithromycin.

TL;DR: In addition to erythromycin, macrolides now available in the United States include azithromycin and clarithromycin this article, which have excellent activity against the atypical respiratory pathogens (C. pneumoniae and Mycoplasma species) and Legionella species.
Journal ArticleDOI

Management of infectious diarrhoea

TL;DR: The role of antimicrobial agents in the management of infective diarrhoea continues to be clarified with the emergence of new agents and simplified treatment regimens.
References
More filters
Book ChapterDOI

State of the World’s Children

TL;DR: Unless urgent improvements in protecting fetal and infant brains can be achieved in both rich and poor countries, developmental-behavioral disorders will emerge by the 21st century as an overriding health issue in many areas of the world.
Journal ArticleDOI

In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection.

TL;DR: The uptake, transport, and later release of azithromycin by these cells demonstrate that phagocytes may deliver active drug to sites of infection.
Journal ArticleDOI

Randomised controlled trial of single-dose azithromycin in treatment of trachoma

TL;DR: A randomised single-blind comparison of azithromycin with conventional treatment in two villages with endemic trachoma in The Gambia found there were no significant differences in treatment effect, baseline characteristics, or re-emergent disease between the treatment groups.
Journal ArticleDOI

Intracellular Accumulation of Azithromycin by Cultured Human Fibroblasts

TL;DR: The widespread distribution of fibroblasts in tissues suggests a potential for these cells, and possibly other lysosome-containing tissue cells, to serve as a reservoir for azithromycin, slowly releasing it for activity against extracellular organisms at sites of infection and passing it to phagocytes for activityagainst intracellular pathogens and potential transport to Sites of infection.
Related Papers (5)